DeepMed Research

WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Emission Patterns of Respiratory Syncytial Virus

Terminated

Conditions: RSV Infection
Aerosol Disease

First Posted Date: 2019-04-10

Last Posted Date: 2025-02-28

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 7

Registration Number: NCT03909867

Locations: 🇺🇸
Wake Forest School of Medicine, Winston-Salem, North Carolina, United States

Social Determinants of Health in Glioblastoma Population

Completed

Conditions: Pleomorphic Xanthoastrocytoma
Oligodendroglioma
Glioma
Ependymoma
Ganglioglioma
Astrocytoma

Interventions: Other: Part 2 Focus Group
Other: Part 1 Survey Group

First Posted Date: 2019-04-03

Last Posted Date: 2023-12-14

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 100

Registration Number: NCT03900689

Locations: 🇺🇸
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity

Recruiting

Conditions: Hematologic Malignancy

First Posted Date: 2019-03-26

Last Posted Date: 2025-03-04

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 70

Registration Number: NCT03890614

Locations: 🇺🇸
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

Rural Survivorship Navigation Program

Completed

Conditions: Cancer

First Posted Date: 2019-03-19

Last Posted Date: 2021-06-30

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 503

Registration Number: NCT03880526

Locations: 🇺🇸
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

EMR Outcomes: Anxiety and Depression in Epilepsy

Not Applicable

Completed

Conditions: Depression
Anxiety
Quality of Life
Epilepsy

Interventions: Other: Telephone-based-standard method
Other: EMR-based-interventional method

First Posted Date: 2019-03-18

Last Posted Date: 2022-01-18

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 30

Registration Number: NCT03879525

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

Extended Release Local Anesthetic for Postsurgical Pain After Posterior Colporrhaphy and Perineorrhaphy

Phase 4

Completed

Conditions: Postoperative Pain

Interventions: Drug: Placebo - injection
Drug: Liposomal bupivacaine

First Posted Date: 2019-03-15

Last Posted Date: 2022-09-13

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 72

Registration Number: NCT03875664

Locations: 🇺🇸
Women's Center for Pelvic Health, Charlotte, North Carolina, United States

CONNECTing Head and Neck Caregivers to Supportive Care Resources

Not Applicable

Completed

Conditions: Head and Neck Cancer

Interventions: Behavioral: CONNECT
Behavioral: CONTROL

First Posted Date: 2019-03-15

Last Posted Date: 2023-04-27

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 40

Registration Number: NCT03875885

Locations: 🇺🇸
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

Medical Data Collection in the Formation of Precision Oncology Registry

Terminated

Conditions: Cancer

First Posted Date: 2019-03-14

Last Posted Date: 2024-01-19

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 2885

Registration Number: NCT03874065

Locations: 🇺🇸
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

Opioid Free Management After Ureteroscopy

Phase 4

Completed

Conditions: Kidney Stone

Interventions: Drug: Norco 5milligram-325milligram Tablet
Drug: Ibuprofen 400 MILLIGRAM in 1 TABLET ORAL TABLET, FILM COATED

First Posted Date: 2019-03-13

Last Posted Date: 2021-03-11

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 22

Registration Number: NCT03872843

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer

Early Phase 1

Terminated

Conditions: Stage IA Lung Carcinoma AJCC V7
Stage IIIA Lung Carcinoma
Stage I Lung Cancer
Stage IIA Lung Carcinoma
Stage Ib Lung Carcinoma
Non Small Cell Lung Cancer

Interventions: Drug: Vitamin A Compound
Procedure: Therapeutic Conventional Surgery

First Posted Date: 2019-03-12

Last Posted Date: 2024-01-09

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 20

Registration Number: NCT03870529

Locations: 🇺🇸
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy